These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4792889)

  • 1. Clinical responses to Cinnarizin in various psychiatric syndromes.
    Szobor A; Klein M
    Ther Hung; 1973; 21(1):31-4. PubMed ID: 4792889
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
    Voina S
    Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
    Toledo JB; Pisa H; Marchese M
    Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of sordinol in mental disordes of vascular origin].
    Romanova IS; Banshchikov VM; Rozhanets RV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1223-8. PubMed ID: 5700590
    [No Abstract]   [Full Text] [Related]  

  • 6. Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
    Nair NP; Ban TA; Hontela S; Clarke R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):769-75. PubMed ID: 4201974
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
    Ban TA; Lehmann HE; Amin M; Bronheim LA; Klingner A; Nair NP; Galvan L; Vergara L; Zoch C
    Int J Clin Pharmacol; 1974 Jan; 9(1):23-7. PubMed ID: 4593127
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychopharmacological treatment of disorders of senescence.
    Fann WE; Wheless JC; Richman BW
    N C Med J; 1974 Nov; 35(11):672-7. PubMed ID: 4530160
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency].
    Digo R; Bellot JC
    Encephale; 1969; 58(3):267-82. PubMed ID: 5378185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electro-clinical study on value of M.D. 1035 in psychiatry].
    Ey H; Barros-Fereira M; Bohard F; Natin JC
    Ann Med Psychol (Paris); 1970 Mar; 1(3):455-65. PubMed ID: 5424185
    [No Abstract]   [Full Text] [Related]  

  • 11. [The value of Sureptil in O.R.L].
    Mounier-Kuhn P; Jacquemard C; Haguenauer JP; Bouchayer M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Oct; 18(8):551-6. PubMed ID: 4249534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of Vascoril].
    Bernasconi P
    Lille Med; 1973 Feb; 18():Suppl 2:237-40. PubMed ID: 4732954
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations on the action of ethyl cinepazate maleate in 67 patients with coronary insufficiency].
    Pino G
    Minerva Cardioangiol; 1974 Dec; 22(12):852-66. PubMed ID: 4459729
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
    Jansen W; O'Connolly M; Lehmann E; Mayer M
    Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged clinical experimentation with MD-1036 in coronary angina].
    Routier MG
    J Sci Med Lille; 1972 Oct; 90(10):359-62. PubMed ID: 4629441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trial of a new coronarydilator].
    Delaage M; Benyamine R; Jouve A
    Coeur Med Interne; 1967 Oct; 6(4):479-81. PubMed ID: 5623598
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of a new anti-angina drug: Vascoril (67 53 MD)].
    Warembourg H; Bertrand M; Ginestet A
    Lille Med; 1972 May; 17():Suppl 4:804-8. PubMed ID: 5056283
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
    Mailland F; Zottino G
    Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a cerebral vasoactive drug, 1035 MD, in 40 adolescents with severe mental retardation].
    Rossignol C
    Rev Neuropsychiatr Infant; 1972 Oct; 20(10):791-7. PubMed ID: 4650286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.